{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:40:17Z","timestamp":1783593617674,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1129-2377-14-66","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T08:14:20Z","timestamp":1375344860000},"source":"Crossref","is-referenced-by-count":53,"title":["Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?"],"prefix":"10.1186","volume":"14","author":[{"given":"Rossella E","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele S","family":"Merki-Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Terreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pellegrinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"311_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ncl.2008.11.011","volume":"27","author":"ME Bigal","year":"2009","unstructured":"Bigal ME, Lipton RB: The epidemiology, burden, and comorbidities of migraine. Neurol Clin 2009, 27: 321\u2013334. 10.1016\/j.ncl.2008.11.011","journal-title":"Neurol Clin"},{"key":"311_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Bas\u00e1\u00f1ez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, et al.: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380: 2163\u20132196. 10.1016\/S0140-6736(12)61729-2","journal-title":"Lancet"},{"key":"311_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68: 343\u2013349. 10.1212\/01.wnl.0000252808.97649.21","journal-title":"Neurology"},{"key":"311_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"S Lj","year":"2007","unstructured":"Lj S, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27: 193\u2013210. 10.1111\/j.1468-2982.2007.01288.x","journal-title":"Cephalalgia"},{"key":"311_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1468-2982.2008.01666.x","volume":"28","author":"WF Stewart","year":"2008","unstructured":"Stewart WF, Wood C, Reed ML, Roy J, Lipton RB, AMPP Advisory Group: Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008, 28: 1170\u20131178. 10.1111\/j.1468-2982.2008.01666.x","journal-title":"Cephalalgia"},{"key":"311_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0072-9752(10)97025-5","volume":"97","author":"RE Nappi","year":"2010","unstructured":"Nappi RE, Berga SL: Migraine and reproductive life. Handb Clin Neurol 2010, 97: 303\u2013322.","journal-title":"Handb Clin Neurol"},{"issue":"29","key":"311_CR7","first-page":"1","volume":"23","author":"WD Mosher","year":"2010","unstructured":"Mosher WD, Jones J: Use of contraception in the United States: 1982\u20132008. Vital Health Stat 2010,23(29):1\u201344.","journal-title":"Vital Health Stat"},{"key":"311_CR8","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.3109\/13625187.2010.533002","volume":"15","author":"SO Skouby","year":"2010","unstructured":"Skouby SO: Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care 2010, 15: S42-S53. 10.3109\/13625187.2010.533002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"311_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4755-10-7","volume":"10","author":"S Johnson","year":"2013","unstructured":"Johnson S, Pion C, Jennings V: Current methods and attitudes of women towards contraception in Europe and America. Reprod Health 2013, 10: 7. 10.1186\/1742-4755-10-7","journal-title":"Reprod Health"},{"key":"311_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ajog.2011.06.056","volume":"205","author":"K Maguire","year":"2011","unstructured":"Maguire K, Westhoff C: The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol 2011, 205: S4-S8. 10.1016\/j.ajog.2011.06.056","journal-title":"Am J Obstet Gynecol"},{"key":"311_CR11","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.ajog.2011.06.057","volume":"205","author":"LP Shulman","year":"2011","unstructured":"Shulman LP: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Am J Obstet Gynecol 2011, 205: S9-S13. 10.1016\/j.ajog.2011.06.057","journal-title":"Am J Obstet Gynecol"},{"key":"311_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.contraception.2012.08.002","volume":"87","author":"R Sitruk-Ware","year":"2013","unstructured":"Sitruk-Ware R, Nath A, Mishell DR Jr: Contraception technology: past, present and future. Contraception 2013, 87: 319\u2013330. 10.1016\/j.contraception.2012.08.002","journal-title":"Contraception"},{"key":"311_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1526-4610.2011.02051.x","volume":"52","author":"A Calhoun","year":"2012","unstructured":"Calhoun A: Combined hormonal contraceptives: is it time to reassess their role in migraine? Headache 2012, 52: 648\u2013660. 10.1111\/j.1526-4610.2011.02051.x","journal-title":"Headache"},{"key":"311_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1526-4610.2005.05049.x","volume":"45","author":"EW Loder","year":"2005","unstructured":"Loder EW, Buse DC, Golub J: Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 2005, 45: 224\u2013231. 10.1111\/j.1526-4610.2005.05049.x","journal-title":"Headache"},{"key":"311_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1783\/147118907781004750","volume":"33","author":"EA MacGregor","year":"2007","unstructured":"MacGregor EA: Migraine and use of combined hormonal contraceptives: a clinical review. J Fam Plann Reprod Health Care 2007, 33: 159\u2013169. 10.1783\/147118907781004750","journal-title":"J Fam Plann Reprod Health Care"},{"key":"311_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.contraception.2012.09.017","volume":"87","author":"MW Steenland","year":"2013","unstructured":"Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM: Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. Contraception 2013, 87: 611\u2013624. 10.1016\/j.contraception.2012.09.017","journal-title":"Contraception"},{"key":"311_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1468-2982.2000.00038.x","volume":"20","author":"H Massiou","year":"2000","unstructured":"Massiou H, MacGregor EA: Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000, 20: 170\u2013174. 10.1046\/j.1468-2982.2000.00038.x","journal-title":"Cephalalgia"},{"key":"311_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1212\/01.wnl.0000196481.57994.09","volume":"66","author":"K Aegidius","year":"2006","unstructured":"Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ: Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 2006, 66: 349\u2013353. 10.1212\/01.wnl.0000196481.57994.09","journal-title":"Neurology"},{"key":"311_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","volume":"20","author":"F Granella","year":"2000","unstructured":"Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Nappi G: Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000, 20: 701\u2013707.","journal-title":"Cephalalgia"},{"key":"311_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0029-7844(02)01984-1","volume":"99","author":"KM Curtis","year":"2002","unstructured":"Curtis KM, Chrisman CE, Peterson HB, WHO Programme for Mapping Best Practices in Reproductive Health: Contraception for women in selected circumstances. Obstet Gynecol 2002, 99: 1100\u20131112. 10.1016\/S0029-7844(02)01984-1","journal-title":"Obstet Gynecol"},{"key":"311_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ajog.2004.12.089","volume":"193","author":"EW Loder","year":"2005","unstructured":"Loder EW, Buse DC, Golub JR: Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 2005, 193: 636\u2013649. 10.1016\/j.ajog.2004.12.089","journal-title":"Am J Obstet Gynecol"},{"key":"311_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11916-012-0293-8","volume":"16","author":"C Tassorelli","year":"2012","unstructured":"Tassorelli C, Greco R, Allena M, Terreno E, Nappi RE: Transdermal hormonal therapy in perimenstrual migraine: why, when and how? Curr Pain Headache Rep 2012, 16: 467\u2013473. 10.1007\/s11916-012-0293-8","journal-title":"Curr Pain Headache Rep"},{"key":"311_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.fertnstert.2011.07.1089","volume":"96","author":"V De Leo","year":"2011","unstructured":"De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A: Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril 2011, 96: 917\u2013920. 10.1016\/j.fertnstert.2011.07.1089","journal-title":"Fertil Steril"},{"key":"311_CR24","volume-title":"Contraception","author":"RE Nappi","year":"2013","unstructured":"Nappi RE, Terreno E, Sances G, Martini E, Tonani S, Santamaria V, Tassorelli C, Spinillo A: Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM). Contraception 2013. Epub ahead of print 10.1016\/j.contraception.2013.02.001"},{"key":"311_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, Coffee A, Clark J: Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007, 47: 27\u201337.","journal-title":"Headache"},{"key":"311_CR26","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","volume":"52","author":"A Calhoun","year":"2012","unstructured":"Calhoun A, Ford S, Pruitt A: The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache 2012, 52: 1246\u20131253. 10.1111\/j.1526-4610.2012.02211.x","journal-title":"Headache"},{"key":"311_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/head.12035","volume":"53","author":"EA MacGregor","year":"2013","unstructured":"MacGregor EA: Contraception and headache. Headache 2013, 53: 247\u2013276. 10.1111\/head.12035","journal-title":"Headache"},{"key":"311_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/bmj.38302.504063.8F","volume":"330","author":"M Etminan","year":"2005","unstructured":"Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330: 63\u201365. 10.1136\/bmj.38302.504063.8F","journal-title":"BMJ"},{"key":"311_CR29","doi-asserted-by":"publisher","first-page":"b3914","DOI":"10.1136\/bmj.b3914","volume":"339","author":"M Schurks","year":"2009","unstructured":"Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T: Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339: b3914. 10.1136\/bmj.b3914","journal-title":"BMJ"},{"key":"311_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.amjmed.2009.12.021","volume":"123","author":"JT Spector","year":"2010","unstructured":"Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S: Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010, 123: 612\u2013624. 10.1016\/j.amjmed.2009.12.021","journal-title":"Am J Med"},{"key":"311_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0333102412451361","volume":"32","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Carolei A: Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia 2012, 32: 785\u2013795. 10.1177\/0333102412451361","journal-title":"Cephalalgia"},{"key":"311_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/01.WNL.0000151857.43225.49","volume":"64","author":"AI Scher","year":"2005","unstructured":"Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ: Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005, 64: 614\u2013620. 10.1212\/01.WNL.0000151857.43225.49","journal-title":"Neurology"},{"key":"311_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10194-012-0424-y","volume":"13","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Degan D, Carolei A: Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 2012, 13: 177\u2013189. 10.1007\/s10194-012-0424-y","journal-title":"J Headache Pain"},{"key":"311_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jama.284.1.72","volume":"284","author":"LA Gillum","year":"2000","unstructured":"Gillum LA, Mamidipudi SK, Johnston SC: Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000, 284: 72\u201378. 10.1001\/jama.284.1.72","journal-title":"JAMA"},{"key":"311_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14737175.9.3.381","volume":"9","author":"G Allais","year":"2009","unstructured":"Allais G, Gabellari IC, De Lorenzo C, Mana O, Benedetto C: Oral contraceptives in migraine. Expert Rev Neurother 2009, 9: 381\u2013393. 10.1586\/14737175.9.3.381","journal-title":"Expert Rev Neurother"},{"key":"311_CR36","doi-asserted-by":"publisher","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"\u00d8 Lidegaard","year":"2009","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL, Agger C: Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009, 339: b2890. 10.1136\/bmj.b2890","journal-title":"BMJ"},{"key":"311_CR37","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"\u00d8 Lidegaard","year":"2011","unstructured":"Lidegaard \u00d8, Nielsen LH, Skovlund CW, Skjeldestad FE, L\u00f8kkegaard E: Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139. BMJ 2011, 343: d6423. 10.1136\/bmj.d6423","journal-title":"BMJ"},{"key":"311_CR38","first-page":"e2990","volume":"344","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, L\u00f8kkegaard E: Venous thrombosis in users of non-oral hormonal contraception: follow-up study. Denmark 2001\u201310 2012, 344: e2990.","journal-title":"Denmark 2001\u201310"},{"key":"311_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","volume":"61","author":"R Sitruk-Ware","year":"2008","unstructured":"Sitruk-Ware R: Pharmacological profile of progestins. Maturitas 2008, 61: 151\u2013157. 10.1016\/j.maturitas.2008.11.011","journal-title":"Maturitas"},{"key":"311_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","volume":"126","author":"SN Tchaikovski","year":"2010","unstructured":"Tchaikovski SN, Rosing J: Mechanisms of estrogen-induced venous thromboembolism. Thromb Res 2010, 126: 5\u201311. 10.1016\/j.thromres.2010.01.045","journal-title":"Thromb Res"},{"key":"311_CR41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","volume":"75","author":"JC Dinger","year":"2007","unstructured":"Dinger JC, Heinemann LAJ, Kuhl-Habich D: The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007, 75: 344\u2013354. 10.1016\/j.contraception.2006.12.019","journal-title":"Contraception"},{"key":"311_CR42","volume-title":"Risk of VTE in users of an etonogestrel-containing vaginal ring combined oral contraceptives. Abstract presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)","author":"J Dinger","year":"2012","unstructured":"Dinger J, Pineda AA: Risk of VTE in users of an etonogestrel-containing vaginal ring combined oral contraceptives. Abstract presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG). San Diego, CA, USA; 2012."},{"key":"311_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","volume":"87","author":"S Sidney","year":"2013","unstructured":"Sidney S, Cheetam TC, Connel FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO: Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception 2013, 87: 93\u2013100. 10.1016\/j.contraception.2012.09.015","journal-title":"Contraception"},{"key":"311_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/13625187.2013.792637","volume":"18","author":"J Bitzer","year":"2013","unstructured":"Bitzer J, Amy JJ, Beerthuizen R, Birkh\u00e4user M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C: Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. Eur J Contracept Reprod Health Care 2013, 18: 143\u2013147. 10.3109\/13625187.2013.792637","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"311_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","volume":"75","author":"LAJ Heinemann","year":"2007","unstructured":"Heinemann LAJ, Dinger JC: Range of published estimates of venous thromboembolism incidence in young women. Contraception 2007, 75: 328\u2013336. 10.1016\/j.contraception.2006.12.018","journal-title":"Contraception"},{"key":"311_CR46","volume-title":"Medical Eligibility for Contraceptive Use (4th edn)","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Medical Eligibility for Contraceptive Use (4th edn). 2010."},{"key":"311_CR47","unstructured":"Faculty of Sexual and Reproductive Healthcare: UK Medical Eligibility Criteria for Contraceptive Use \u2013 November 2009. Revised May 2010."},{"key":"311_CR48","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ajog.2011.04.033","volume":"205","author":"AE Burke","year":"2011","unstructured":"Burke AE: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives. Am J Obstet Gynecol 2011, 205: S14-S17. 10.1016\/j.ajog.2011.04.033","journal-title":"Am J Obstet Gynecol"},{"key":"311_CR49","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/0010-7824(94)90124-4","volume":"50","author":"MF McCann","year":"1994","unstructured":"McCann MF, Potter LS: Progestin-only oral contraception: a comprehensive review. Contraception 1994, 50: S1-S195. 10.1016\/0010-7824(94)90076-0","journal-title":"Contraception"},{"key":"311_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/13625189809167250","volume":"3","author":"Collaborative Study Group on the Desogestrel-Containing Progestogen-Only Pill","year":"1998","unstructured":"Collaborative Study Group on the Desogestrel-Containing Progestogen-Only Pill: A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 \u03bcg\/day and levonorgestrel 30 \u03bc\/day. Eur J Contracep Reprod Health Care 1998, 3: 169\u2013178. 10.3109\/13625189809167250","journal-title":"Eur J Contracep Reprod Health Care"},{"key":"311_CR51","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2165\/00002018-200427150-00003","volume":"27","author":"T Backman","year":"2004","unstructured":"Backman T: Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf 2004, 27: 1185\u20131204. 10.2165\/00002018-200427150-00003","journal-title":"Drug Saf"},{"key":"311_CR52","first-page":"CD001326","volume-title":"Cochrane Database Syst Rev","author":"J Power","year":"2007","unstructured":"Power J, French R, Cowan F: Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007, CD001326."},{"key":"311_CR53","doi-asserted-by":"publisher","first-page":"e4944","DOI":"10.1136\/bmj.e4944","volume":"345","author":"S Mantha","year":"2012","unstructured":"Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI: Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012, 345: e4944. 10.1136\/bmj.e4944","journal-title":"BMJ"},{"key":"311_CR54","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","volume":"40","author":"Z Chakhtoura","year":"2009","unstructured":"Chakhtoura Z, Canonico M, Gompel A, Thalabard JC, Scarabin PY, Plu-Bureau G: Progestogen-only contraceptives and the risk of stroke: a metaanalysis. Stroke 2009, 40: 1059\u20131062. 10.1161\/STROKEAHA.108.538405","journal-title":"Stroke"},{"key":"311_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1468-2982.2004.00748.x","volume":"24","author":"L Kelman","year":"2004","unstructured":"Kelman L: The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004, 24: 728\u2013734. 10.1111\/j.1468-2982.2004.00748.x","journal-title":"Cephalalgia"},{"key":"311_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.contraception.2012.06.010","volume":"86","author":"JT Jensen","year":"2012","unstructured":"Jensen JT, Trussell J: Communicating risk: does scientific debate compromise safety. Contraception 2012, 86: 327\u2013329. 10.1016\/j.contraception.2012.06.010","journal-title":"Contraception"},{"key":"311_CR57","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","volume":"366","author":"\u00d8 Lidegaard","year":"2012","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Jensen A, Skovlund CW, Keiding N: Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012, 366: 2257\u20132266. 10.1056\/NEJMoa1111840","journal-title":"N Engl J Med"},{"key":"311_CR58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/WNL.22.4.355","volume":"22","author":"BW Somerville","year":"1972","unstructured":"Somerville BW: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22: 355\u2013365. 10.1212\/WNL.22.4.355","journal-title":"Neurology"},{"key":"311_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.25.3.245","volume":"25","author":"BW Somerville","year":"1972","unstructured":"Somerville BW: Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1972, 25: 245\u2013250.","journal-title":"Neurology"},{"key":"311_CR60","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1526-4610.2012.02249.x","volume":"53","author":"R Greco","year":"2013","unstructured":"Greco R, Tassorelli C, Mangione AS, Smeraldi A, Allena M, Sandrini G, Nappi G, Nappi RE: Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache 2013, 53: 288\u2013296. 10.1111\/j.1526-4610.2012.02249.x","journal-title":"Headache"},{"key":"311_CR61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1526-4610.2011.01903.x","volume":"51","author":"H Bolay","year":"2011","unstructured":"Bolay H, Berman NE, Akcali D: Sex-related differences in animal models of migraine headache. Headache 2011, 51: 891\u2013904. 10.1111\/j.1526-4610.2011.01903.x","journal-title":"Headache"},{"key":"311_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1526-4610.2006.00309.x","volume":"46","author":"VT Martin","year":"2006","unstructured":"Martin VT, Behbehani M: Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis\u2013part i. Headache 2006, 46: 3\u201323. 10.1111\/j.1526-4610.2006.00309.x","journal-title":"Headache"},{"key":"311_CR63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2826.2008.01801.x","volume":"21","author":"A Jayaraman","year":"2009","unstructured":"Jayaraman A, Pike CJ: Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 2009, 21: 77\u201381. 10.1111\/j.1365-2826.2008.01801.x","journal-title":"J Neuroendocrinol"},{"key":"311_CR64","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1526-4610.2007.00818.x","volume":"47","author":"K Eikermann-Haerter","year":"2007","unstructured":"Eikermann-Haerter K, Kudo C, Moskowitz MA: Cortical spreading depression and estrogen. Headache 2007, 47: S79-S85. 10.1111\/j.1526-4610.2007.00818.x","journal-title":"Headache"},{"key":"311_CR65","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","volume":"84","author":"J Endrikat","year":"2011","unstructured":"Endrikat J, Gerlinger C, Richard S, Rosenbaum P, D\u00fcsterberg B: Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception 2011, 84: 549\u2013557. 10.1016\/j.contraception.2011.04.009","journal-title":"Contraception"},{"key":"311_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0010-7824(01)00284-0","volume":"65","author":"A Glasier","year":"2002","unstructured":"Glasier A: Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002, 65: 29\u201337. 10.1016\/S0010-7824(01)00284-0","journal-title":"Contraception"},{"key":"311_CR67","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0010-7824(78)90001-X","volume":"17","author":"WH Organization","year":"1978","unstructured":"Organization WH: Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects. Contraception 1978, 17: 395\u2013406. 10.1016\/0010-7824(78)90001-X","journal-title":"Contraception"},{"key":"311_CR68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5694\/j.1326-5377.1970.tb84395.x","volume":"1","author":"B Somerville","year":"1970","unstructured":"Somerville B, Carey M: The use of continuous progestogen contraception in the treatment of migraine. Med J Aust 1970, 1: 1043\u20131045.","journal-title":"Med J Aust"},{"key":"311_CR69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.contraception.2010.07.024","volume":"83","author":"RE Nappi","year":"2011","unstructured":"Nappi RE, Sances G, Allais G, Terreno E, Benedetto C, Vaccaro V, Polatti F, Facchinetti F: Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception 2011, 83: 223\u2013228. 10.1016\/j.contraception.2010.07.024","journal-title":"Contraception"},{"key":"311_CR70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0333102412473373","volume":"33","author":"GS Merki-Feld","year":"2013","unstructured":"Merki-Feld GS, Imthurn B, Langner R, Sandor PS, Gantenbein AR: Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study. Cephalalgia 2013, 33: 340\u2013346. 10.1177\/0333102412473373","journal-title":"Cephalalgia"},{"key":"311_CR71","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/oxfordjournals.humrep.a019245","volume":"11","author":"C Rice","year":"1996","unstructured":"Rice C, Killick S, Hickling D, Coelingh Bennink H: Ovarian activity and vaginal bleeding patterns with a desogestrel-only preparation at three different doses. Hum Reprod 1996, 11: 737\u2013740. 10.1093\/oxfordjournals.humrep.a019245","journal-title":"Hum Reprod"},{"key":"311_CR72","volume-title":"Eur J Contracep Reprod Health Care","author":"IB Merki-Feld GS","year":"2013","unstructured":"Merki-Feld GS IB, Seifert B, Merki LL, Agosti R, Gantenbein AR: Desogestrel-only contraception reduces headache frequency and improves quality of life in female migraineurs. Eur J Contracep Reprod Health Care 2013. in press"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1129-2377-14-66\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1129-2377-14-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1129-2377-14-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:31:43Z","timestamp":1715808703000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/1129-2377-14-66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1186\/1129-2377-14-66","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]},"article-number":"66"}}